title: Practice parameters for the management of Clostridium difficile infection.
authors.affiliation: Prepared by the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons.
authors.forename: Scott R
authors.initials: SR
authors.lastname: Steele
authors.forename: James
authors.initials: J
authors.lastname: McCormick
authors.forename: Genevieve B
authors.initials: GB
authors.lastname: Melton
authors.forename: Ian
authors.initials: I
authors.lastname: Paquette
authors.forename: David E
authors.initials: DE
authors.lastname: Rivadeneira
authors.forename: David
authors.initials: D
authors.lastname: Stewart
authors.forename: W Donald
authors.initials: WD
authors.lastname: Buie
authors.forename: Janice
authors.initials: J
authors.lastname: Rafferty
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000472:pathogenicity*; D003015:Clostridium Infections / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D013505:Digestive System Surgical Procedures; D019317:Evidence-Based Medicine; D006801:Humans; D017053:Infection Control / Q000379:methods; D019936:Probiotics / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents